Retinaldehyde sits one conversion step closer to retinoic acid than retinol does, which is the real source of its speed. Here is what that means in practice, why so many retinaldehyde formulas underdelivered until recently, and why the gentler claim rests on a different comparison.
· 7 min read
Search interest in retinol vs retinal keeps climbing as more brands lead with retinaldehyde. The pitch is simple: same vitamin A family, fewer steps to the active form, faster results. That part is true. What gets glossed over is why retinaldehyde spent years underperforming its own chemistry, what changed recently enough to matter, and why the popular claim that it is also the gentler of the two rests on a study that pitted both against retinoic acid instead.
All over-the-counter retinoids start life as some form of vitamin A and have to convert inside the skin to reach retinoic acid, the form that actually binds retinoic acid receptors and drives cell turnover. Retinyl esters convert to retinol, retinol converts to retinaldehyde (also called retinal), and retinaldehyde converts to retinoic acid. Retinol needs two enzymatic conversions to get there. Retinaldehyde needs one. A 2006 review in Clinical Interventions in Aging puts retinol at roughly 20 times less potent than retinoic acid on a molar basis, with retinal sitting in between. Prescription tretinoin skips the line entirely because it already is retinoic acid, which is also why it tends to produce more visible dryness and flaking at the start of use.
Fewer conversion steps generally means faster onset and less of the ingredient lost along the way, since each enzymatic step is a place for potency to drop off. Brand-side comparisons go further, with Medik8 marketing its Crystal Retinal line on the claim that retinal works roughly eleven times faster than retinol at delivering visible improvements and supporting collagen. That figure comes from the brand, not an independent trial, so read it as a positioning claim rather than an established clinical result. The mechanism behind it, the shorter conversion path, is well documented in dermatology literature.
The most concrete recent evidence comes from a study published in the Journal of Drugs in Dermatology in November 2024, testing a 0.1% retinaldehyde serum formulated with firming peptides, ceramides, and lipids on 32 women, nearly half with skin of color and more than half self-identifying as sensitive. Applied three nights a week for eight weeks, the formula was associated with a 12% improvement in visible facial fine lines, a 19% improvement in chest fine lines, a 19% reduction in visible hyperpigmentation, a 5% improvement in facial texture, and a 20% improvement in visible pore appearance, all statistically significant. Patch testing in the same study found no signs of sensitization or irritation. That is a modest, real dataset, not a sweeping one, and it describes one specific formula rather than retinaldehyde as an ingredient class.
The same proximity to retinoic acid that makes retinaldehyde fast also makes it chemically unstable. Retinaldehyde oxidizes readily when exposed to air, light, and heat, and older formulations frequently degraded before they ever reached the skin, which helps explain why plenty of early retinaldehyde products earned a reputation for underwhelming results despite the favorable chemistry. Delivery technology has been the actual bottleneck, not the molecule.
Prequel's Retinal Renew gel, updated on the brand's site in November 2025, encapsulates retinaldehyde in calcium-based microparticles under the name Hydroxysomes, designed to protect the ingredient until it reaches the skin and then release it gradually, and pairs it with ectoin and cica as buffering agents. Medik8's Crystal Retinal line relies on its own patented stabilization system across six strength tiers from 0.01% to 0.24% for the same reason. Recent retinaldehyde launches are a story about formulation catching up to the molecule.
The most repeated line about retinal online is that it is gentler than retinol. The foundational tolerance research is a 1999 study in Dermatology that ran a 14-day repeated-insult patch test comparing retinol, retinaldehyde and retinoic acid, followed by a 44-week clinical study of 355 subjects using retinaldehyde or retinoic acid. Under the intensive patch-test conditions, both retinol and retinaldehyde caused significantly less irritation than retinoic acid, but they were not identical to each other: retinaldehyde tended to produce more scaling than retinol, while retinol tended to produce more burning and stinging than retinaldehyde. In the long-term arm, the retinoic acid group showed a 44% rate of redness, a 35% rate of scaling, and a 29% rate of burning or stinging within four weeks, versus substantially lower rates for the retinaldehyde group.
In other words, the study behind the gentler-than-retinol claim compared both cosmetic forms against prescription-strength retinoic acid, not retinol against retinal at matched, beginner-friendly strengths. Which of the two irritates more depends on the skin and the specific side effect, not a fixed hierarchy.
Current dermatologist guidance reflects that nuance. In a May 2026 NBC News roundup, dermatologist Gloria Lin described retinal as considered the most effective retinoid available without a prescription, but recommended that people with dry or sensitive skin start with retinol and move to retinal once they have built tolerance. Dermatologist Julie Russak told the same outlet that retinal is generally better tolerated because it needs fewer conversions to become active, which can mean fewer byproducts triggering irritation along the way. Retinol, meanwhile, has the longer track record and the widest range of strengths, which makes it easier to titrate slowly for a first-time user.
Concentration complicates the picture further. The Ordinary's Retinal 0.2% Emulsion is marketed as the brand's most potent retinoid rather than its most tolerable one, and a reviewer who has used it alongside the brand's retinol line describes it as more sensitizing at that concentration and not appropriate for first-time retinoid users or reactive skin. Potency and tolerability are set by formulation and percentage, not by the molecule's name alone.
Any vitamin A derivative can increase sun sensitivity, so daytime SPF is not optional while using one. If skin is showing signs of redness or a compromised barrier, it is worth easing in with a lower strength or a buffered formula, and applying over moisturizer rather than directly onto bare skin at first. Anyone pregnant or trying to conceive should talk to their doctor about whether to use vitamin A derivatives at all.
Start low regardless of which form is chosen. For retinol, that typically means a 0.25% to 0.3% product two to three nights a week, working up gradually as skin tolerates it. For retinaldehyde, both Prequel and Medik8 offer sub-0.1% entry points aimed at first-time users for the same reason. Apply at night, after cleansing and before a moisturizer that supports the skin barrier, and give any new retinoid four to six weeks before judging whether it is working, since visible change in the JDD study only became statistically meaningful by the eight-week mark. Switching from a retinol already in use? Substitute one retinol night a week with the retinal product and watch the following two weeks before adding a second night, keeping the rest of the routine unchanged so any new redness or flaking is attributable to the new ingredient. Avoid layering a fresh retinoid on the same night as a strong exfoliating acid until skin has adjusted.
Retinaldehyde is not a different ingredient category; it is the same vitamin A pathway one step further along, which is why it can act faster but why it was also harder to stabilize into a product that delivers that speed. Faster and gentler are two different claims resting on two different pieces of research, and the percentage on the label matters more than the name. If already using and tolerating a retinol without issue, there is no urgent reason to switch. If starting fresh, a buffered, encapsulated retinaldehyde formula at a low strength is a reasonable place to begin, paired with daytime SPF and a barrier-supporting moisturizer, and eight weeks of consistent use before drawing conclusions either way.
Rituelle reads your skin over time and adapts your routine to it.
Join the waitlist
Ingredients
PDRN, the DNA-fragment ingredient behind a wave of firming-skin claims, has a small tolerance case series, animal data and delivery research. Here is what that does and does not add up to.
5 min read
Ingredients
Searches for niacinamide supplements are rising alongside serums. Here is what 2% topical studies show, what the high-dose oral trials were really about, and how to read the label.
5 min read
Decoding Labels
Tone-up creams are still around, but a pink brightening base is not automatically sun protection. Three label checks, grounded in FDA guidance, separate real sunscreen from makeup.
5 min read
